A possible mechanism of hyperlipidemia in a patient with metastatic non-small cell lung cancer on lorlatinib therapy.
J Oncol Pharm Pract
; 27(8): 2010-2013, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-33789526
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Hyperlipidemias
/
Lung Neoplasms
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
J Oncol Pharm Pract
Journal subject:
FARMACIA
Year:
2021
Type:
Article
Affiliation country:
United States